{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:36:10Z","timestamp":1780727770324,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"LOEWE Cell and Gene Therapy Frankfurt faculty"},{"name":"Hessian Ministry of Higher Education, Research and the Arts","award":["III L 4-518\/17.004 (2013)"],"award-info":[{"award-number":["III L 4-518\/17.004 (2013)"]}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jcyt.2018.01.006","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T21:56:17Z","timestamp":1519941377000},"page":"532-542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells"],"prefix":"10.1016","volume":"20","author":[{"given":"Nina","family":"M\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Landwehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-5515","authenticated-orcid":false,"given":"Walter","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno A.W.G.","family":"van der Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhard","family":"Seifried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halvard","family":"Bonig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2018.01.006_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood.V25.2.179.179","article-title":"Successful allogenic bone marrow transplantation in man: chimerism, induced specific tolerance and possible anti-leukemic effects","volume":"25","author":"Mathe","year":"1965","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nri1292","article-title":"The many important facets of T-cell repertoire diversity","volume":"4","author":"Nikolich-Zugich","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0020","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ejh.12283","article-title":"Naive subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting","volume":"92","author":"Cherel","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0030","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3324\/haematol.2010.037481","article-title":"Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells","volume":"96","author":"Distler","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150434","article-title":"CD45 isoform profile identifies Natural Killer (NK) subsets with differential activity","volume":"11","author":"Krzywinska","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-3083.1991.tb01547.x","article-title":"The role of CD45RA on human B-cell function: anti-CD45RA antibody (anti-2H4) inhibits the activation of resting B cells and antibody production of activated B cells independently in humans","volume":"34","author":"Morikawa","year":"1991","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1084\/jem.186.9.1407","article-title":"Phenotypic and functional separation of memory and effector human CD8+ T cells","volume":"186","author":"Hamann","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0050","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/intimm\/3.7.691","article-title":"Expression of CD45 isoforms by fresh and activated human gamma delta T lymphocytes and natural killer cells","volume":"3","author":"Braakman","year":"1991","journal-title":"Int Immunol"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.1994.tb04972.x","article-title":"CD45 isoform expression on human haemopoietic cells at different stages of development","volume":"88","author":"Craig","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0060","first-page":"169","article-title":"The composition of CD34 subpopulations differs between bone marrow, blood and cord blood","volume":"17","author":"Fritsch","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0065","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jcyt.2016.07.001","article-title":"Feasibility of CD3\/CD19 depletion of a bone marrow graft","volume":"18","author":"Bonig","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/bmt.2013.114","article-title":"Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis","volume":"49","author":"Teschner","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0075","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.bbmt.2012.11.477","article-title":"Depletion of naive t cells from peripheral blood stem cell grafts for GVHD prevention","volume":"19","author":"Bleakley","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.bbmt.2014.01.032","article-title":"Engineering human peripheral blood stem cell grafts that are depleted of naive T cells and retain functional pathogen-specific memory T cells","volume":"20","author":"Bleakley","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0085","first-page":"S218","article-title":"Effective depletion of CD45RA+ naive T cells using the CLINIMACS System to produce donor lymphocyte infusions for antiviral boost following haploidentical transplantation","volume":"49","author":"Dykes","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0090","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0095","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jaci.2014.08.019","article-title":"CD45RA depletion in HLA-mismatched allogeneic hematopoietic stem cell transplantation for primary combined immunodeficiency: a preliminary study","volume":"135","author":"Touzot","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0100","first-page":"S353","article-title":"Clinical outcome, safety and rapid immunologic reconstitution in CD45RA-depleted haploidentical transplantation in paediatric acute leukemia treatment","volume":"52","author":"Gasior Kabat","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0105","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/bmt.2014.324","article-title":"Rapid memory T-cell reconstitution recapitulating CD45RA-depleted haploidentical transplant graft content in patients with hematologic malignancies","volume":"50","author":"Triplett","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0110","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/pbc.25352","article-title":"Haploidentical stem cell transplantation augmented by CD45RA negative lymphocytes provides rapid engraftment and excellent tolerability","volume":"62","author":"Shook","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0115","first-page":"S248","article-title":"CD45RA depleted donor lymphocyte infusions for antiviral boost following ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation","volume":"50","author":"Turkiewicz","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13023-016-0385-3","article-title":"Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions","volume":"11","author":"Brodszki","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0125","first-page":"S99","article-title":"Low-dose infusions of CD45RA-depleted donor lymphocytes to improve immune reconstitution after TCR alpha\/beta-depleted transplantation\u2014results of a pilot trial","volume":"51","author":"Blagov","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0130","first-page":"S507","article-title":"Safety of dose escalating haploidentical memory T cell donor lymphocyte infusions after CD45RA-depleted haplo-stem cell transplantation","volume":"52","author":"Mozo","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0135","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/vox.12540","article-title":"Evolution of MNC and lymphocyte collection settings employing different Spectra Optia((R)) Leukapheresis systems","volume":"112","author":"Punzel","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0140","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jcyt.2015.04.005","article-title":"Automated CD34+ cell isolation of peripheral blood stem cell apheresis product","volume":"17","author":"Spohn","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/vox.12291","article-title":"Automated isolation of primary antigen-specific T cells from donor lymphocyte concentrates: results of a feasibility exercise","volume":"109","author":"Bunos","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0150","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12967-016-0826-8","article-title":"Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure","volume":"14","author":"Hummer","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0155","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/intimm\/dxn075","article-title":"Phenotypic classification of human CD4+ T cell subsets and their differentiation","volume":"20","author":"Okada","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0160","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1182\/blood-2014-06-578989","article-title":"Big bang theory of stem-like T cells confirmed","volume":"124","author":"Restifo","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0165","doi-asserted-by":"crossref","first-page":"D805","DOI":"10.1093\/nar\/gkl767","article-title":"qPrimerDepot: a primer database for quantitative real time PCR","volume":"35","author":"Cui","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0170","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1016\/S0021-9258(19)50549-X","article-title":"The alternative splicing of the CD45 tyrosine phosphatase is controlled by negative regulatory trans-acting splicing factors","volume":"267","author":"Rothstein","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0175","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.jcyt.2015.05.011","article-title":"Clinical-scale isolation of the total Aspergillus fumigatus-reactive T-helper cell repertoire for adoptive transfer","volume":"17","author":"Bacher","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0180","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1038\/leu.2017.16","article-title":"Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT","volume":"31","author":"Neuenhahn","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2018.01.006_bib0185","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918300124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918300124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:34:38Z","timestamp":1761442478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324918300124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1465324918300124"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.01.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation of alloreactivity-reduced donor lymphocyte products retaining memory function by fully automatic depletion of CD45RA-positive cells","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2018.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}